pirfenidone and nintedanib
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Hospices Civils de Lyon
Overview
pirfenidone and nintedanib is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
pirfenidone and nintedanib clinical trials
Explore related
Medical disclaimer. This page summarizes research about pirfenidone and nintedanib for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.